Drug Profile
(+)-Calanolide A
Alternative Names: Calanolide A; NSC 664737; NSC 675451Latest Information Update: 27 Apr 2011
Price :
$50
*
At a glance
- Originator National Institutes of Health (USA)
- Developer Sarawak MediChem Pharmaceuticals
- Class Antiretrovirals
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections; Tuberculosis